Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
CRADA with ImmunityBio
Grant: NA
National Institute on Deafness and Other Communication Disorders
Grant: ZIA BC 010944
NIH Medical Research Scholars Program
Grant: DDCF Grant #2014194
National Institutes of Health
Grant: 1ZIABC010944-10
Strategies for Cancer Immunotherapy Development: Preclinical Studies
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals